首页 | 官方网站   微博 | 高级检索  
     

11C-AZD9291 分子探针检测肺癌EGFR 19del 突变的实验研究
引用本文:刘佳,马进安,张锦明,赵颜忠,罗丹静,张晓军,付华平,阙凯琳,韩宸,张颖.11C-AZD9291 分子探针检测肺癌EGFR 19del 突变的实验研究[J].中国现代医学杂志,2020,30(2):1-5.
作者姓名:刘佳  马进安  张锦明  赵颜忠  罗丹静  张晓军  付华平  阙凯琳  韩宸  张颖
作者单位:(1. 中南大学湘雅二医院 肿瘤科,湖南 长沙 410011 ;2. 中国人民解放军301 医院 核医 学科,北京 100039 ;3. 中南大学湘雅三医院 医学实验中心,湖南 长沙 410013)
基金项目:国家自然科学基金(No :81771896)
摘    要:目的 从动物实验探索11C-AZD9291 作为PET/CT 示踪剂检测肺癌EGFR 19del 突变的可行性。 方法 将普通昆明小鼠随机分组并尾静脉注射11C-AZD9291,分别于不同时间点取不同小鼠器官并计算放射 性摄取率。选取EGFR 19del 突变的HCC827、EGFR 野生型A549 肺腺癌细胞株并复制肺癌裸鼠模型,挑选 合格的HCC827 荷瘤鼠6 只分为实验组和阻断组。实验组尾静脉注射11C-AZD9291 ;阻断组同时注射阻断 剂厄洛替尼标准品和11C-AZD9291,另取3 只A549 荷瘤鼠仅尾静脉注射11C-AZD9291 作为对照组,20 min 后行micro-PET 动物活体显像与分析。结果 普通昆明小鼠中11C-AZD9291 在肝脏中放射性摄取率最高, 其次为肾脏、肺,5 min 时血、肝、肾、肺、心及肌肉放射性摄取率较15 min 时高(P <0.05)。实验组标准 摄取值高于对照组和阻断组(P <0.05)。结论 11C-AZD9291 是一种可行的检测肺癌EGFR 19del 突变的分 子探针。

关 键 词:肺肿瘤  11C-AZD9291/  分子探针  放射性
收稿时间:2019/7/25 0:00:00

Experimental study on the detection of EGFR 19del mutation in lung cancer by 11C-AZD9291 molecular probe
Jia Liu,Jin-an M,Jin-ming Zhang,Yan-zhong Zhao,Dan-jing Luo,Xiao-jun Zhang,Hua-ping Fu,Kai-lin Que,Chen Han,Ying Zhang.Experimental study on the detection of EGFR 19del mutation in lung cancer by 11C-AZD9291 molecular probe[J].China Journal of Modern Medicine,2020,30(2):1-5.
Authors:Jia Liu  Jin-an M  Jin-ming Zhang  Yan-zhong Zhao  Dan-jing Luo  Xiao-jun Zhang  Hua-ping Fu  Kai-lin Que  Chen Han  Ying Zhang
Affiliation:(1.Department of Oncology, The Second Xiangya Hospital, Central South University, Changsha, Hunan 410011, China; 2.Department of Nuclear Medicine, PLA 301 Hospital, Beijing 100039, China; 3.Medical Laboratory Center, The Third Xiangya Hospital, Central South University, Changsha, Hunan 410013, China)
Abstract:Objective To explore the feasibility of 11C-AZD9291 as a Micro PET-CT tracer for the detection of EGFR 19del mutation in lung cancer at the level of experimental animals. Methods The normal Kunming mice were injected with 11C-AZD9291 via tail vein, and were executed at different time points. The radioactive counting (%ID/g) was calculated for multiple organs of the mice. Lung adenocarcinoma cell lines HCC827 (EGFR 19del mutation) and A549 (EGFR wild-type) were used to construct the nude mouse models of lung cancer. Six eligible nude mice with HCC827 tumor were selected, and were divided into experimental group and blocking group. In the experimental group, 11C-AZD9291 was injected into the tail vein. The blocking group was injected with erlotinib and 11C-AZD9291 simultaneously. Other three nude mice transplanted with A549 was injected 11C-AZD9291 via tail vein as EGFR wildtype control group. After 20min, animal in-vivo imaging and analysis were performed by micro-pet (Explore Vista, GE). The independent-samples T test and one way ANOVA were used for statistical analysis. Results Kunming mice had the highest radiation uptake rate of 11C-AZD9291 in the liver, followed by kidney and lung. The radiation uptake rate in each organ at time point of 5min was higher than that at 15min (P < 0.05). And the radiation uptake rate in experiment group was higher than that in blocking group or control group. Conclusions At the level of experimental animals, 11C-AZD9291 is a good specific molecular probe for the detection of EGFR 19del mutation in lung cancer.
Keywords:lung neoplasms  11C-azd9291/molecular probes  radiation
点击此处可从《中国现代医学杂志》浏览原始摘要信息
点击此处可从《中国现代医学杂志》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司    京ICP备09084417号-23

京公网安备 11010802026262号